ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ - Mollis Shanghai UniClub

ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ

 ÕÒ»ØÃÜÂë
 »¶Ó­¼ÓÈë һͬ×ÊѶ
http://www.danlan.org/new/UploadFile/201712/20171214/ea_20
http://www.danlan.org/new/UploadFile/201712/20171201/ea_20171211
http://www.danlan.org/new/UploadFile/20170
http://www.danlan.org/new/UploadFile/201712/20171212/ea_20171212221732992.jpg ɽÎ÷Ê¡ÎÀÉú¼

Gilead×éºÏÁÆ·¨ÒÖÖÆHIVÏÔ³ÉЧ

2018-7-27 16:40| ·¢²¼Õß: admin| ²é¿´: 771| ÆÀÂÛ: 0

ÕªÒª: ÓÐÍû¸ù³ýHIV¸ÐȾ£¿Gilead×éºÏÁÆ·¨ÕÃÏÔ³ÉЧ¡¡¡¡¡¾½­ËÕͬ־»áËù¡¿Ò©Ã÷¿µµÂ/±¨µÀ£ºÈÕǰ£¬Gilead SciencesÐû²¼£¬ÆäÓëBeth Israel DeaconessҽѧÖÐÐĺÏ×÷½øÐеÄÁÙ´²Ç°Ñо¿Ö¤Ã÷£¬Ê¹ÓÃGS-9620ÓëPGT121×éºÏÖÎÁÆ¿ÉÒÔʹ¸ÐȾÁË ...

ÓÐÍû¸ù³ýHIV¸ÐȾ£¿Gilead×éºÏÁÆ·¨ÕÃÏÔ³ÉЧ

¡¡¡¡¡¾½­ËÕͬ־»áËù¡¿Ò©Ã÷¿µµÂ/±¨µÀ£ºÈÕǰ£¬Gilead SciencesÐû²¼£¬ÆäÓëBeth Israel DeaconessҽѧÖÐÐĺÏ×÷½øÐеÄÁÙ´²Ç°Ñо¿Ö¤Ã÷£¬Ê¹ÓÃGS-9620ÓëPGT121×éºÏÖÎÁÆ¿ÉÒÔʹ¸ÐȾÁËÔ³ºï-ÈËÃâÒßȱÏݲ¡¶¾(SHIV)µÄºãºÓºïÔÚÍ£Ö¹¿¹Äæ×ªÂ¼²¡¶¾ÁÆ·¨(ART)ºó£¬ÈÔÄÜά³Ö²¡¶¾ÒÖÖÆ¡£ÕâЩÊý¾Ý·¢±íÔÚ2018ÄêÄæ×ªÂ¼²¡¶¾ºÍ»ú»áÐÔ¸ÐȾ»áÒé(CROI)ÉÏ£¬Ö§³Ö¶ÔÉæ¼°ÕâÁ½ÀàÒ©ÎïµÄ×éºÏ²ßÂÔ½øÐнøÒ»²½µÄÑо¿£¬ÒÔ̽Ë÷ʵÏÖ²»ÐèÿÈÕART¼´ÄÜ´ïµ½³¤ÆÚ²¡¶¾ÒÖÖÆµÄ¿ÉÄÜ¡£

¡¡¡¡ÈËÃâÒßȱÏݲ¡¶¾(HIV)Äܹ»¹¥»÷ÈËÌåµÄÃâÒßϵͳ£¬ÌرðÊÇTÁܰÍϸ°û¡£Èç¹û²»½ÓÊÜÖÎÁÆ£¬HIV»á¼õÉÙÌåÄÚTϸ°ûµÄÊýÁ¿£¬µ¼ÖÂÈËÌåµÖ¿¹¸ÐȾºÍÆäËü¼²²¡µÄÄÜÁ¦²»¶ÏϽµ¡£ËäȻͨ¹ýART¿ÉÒÔ¶ÔHIV½øÐÐÓÐЧ¿ØÖÆ£¬ÑÓ³¤°¬×̲¡»¼ÕßµÄÊÙÃü£¬µ«Æù½ñΪֹ£¬ÈÔûÓÐÄܹ»ÍêÈ«Ïû³ýHIVµÄ·½·¨£¬´Ó¶ø³¹µ×ÖÎÓú°¬×̲¡¡£ÕâÒ»ÁìÓò»¹Óо޴óµÄÒ½ÁÆÐèÇó´ýÂú×ã¡£

¡¡¡¡ÕâÏîÑо¿ÖÐÉæ¼°µÄGS-9620ÓëPGT121·Ö±ðÊÇGileadרÓеÄÔÚÑпڷþTollÑùÊÜÌå7(TLR7)¼¤¶¯¼ÁºÍ¹ãÆ×ÖкͿ¹Ìå(bNAb)PGT121£¬ËüÃÇ×÷ΪHIV¸ù³ý²ßÂÔµÄÒ»²¿·Ö£¬ÔÚÁÙ´²Ç°Ñо¿ÖнøÐÐÆÀ¹À¡£

¡¡¡¡ÔÚÕâÏîÑо¿ÖУ¬44Ö»¸ÐȾÁËSHIVµÄºãºÓºïÔÚ¸ÐȾºóµÚ7Ì쿪ʼART¡£¾­¹ýÁ¬Ðø96ÖܵÄARTÖÎÁƺó£¬ÕâЩ¶¯Îï±»·Ö³ÉËÄ×飬·Ö±ð½ÓÊÜ5¼ÁÁ¿µÄPGT121(ÿÁ½ÖÜÊä×¢10mg/kg³ÖÐø10ÖÜ)(n=11)£¬10¼ÁÁ¿µÄGS-9620(ÿÁ½Öܹà×¢0.15mg/kg³ÖÐø20ÖÜ)(n=11)£¬PGT121ºÍGS-9620×éºÏÖÎÁÆ(n=11)£¬»ò²»°üº¬Á½Õߵݲο¼ÁÖÎÁÆ(n=11)¡£¶¯ÎïÔÚ´ËÆÚ¼ä¼°Ö®ºóµÄ16ÖܳÖÐø½ÓÊÜARTÖÎÁÆ¡£ARTÔÚµÚ130ÖÜÍ£Ö¹£¬²¢ÔÚѪ½¬Öмà²â²¡¶¾·´µ¯¡£

¡¡¡¡ARTÍ£Ö¹ºó£¬°²Î¿¼Á×éµÄ11Ö»¶¯Îï¾ù³öÏÖ²¡¶¾·´µ¯£¬ÖÐλ·´µ¯Ê±¼äΪ21Ì죻9Ö»½ÓÊÜPGT121µÄ¶¯Îï³öÏÖ²¡¶¾·´µ¯£»10Ö»½ÓÊÜGS-9620µÄ¶¯Îï³öÏÖ²¡¶¾·´µ¯¡£Ïà±È֮ϣ¬ÓÐ5Ö»½ÓÊÜPGT121ºÍGS-9620×éºÏÖÎÁƵ͝ÎïÔÚÖÁÉÙ168ÌìÄÚûÓÐÏÔʾ³ö²¡¶¾·´µ¯£»¸Ã×éºÏÖÎÁÆÖеÄÁíÍâ6Ö»¶¯ÎïËä³öÏÖ·´µ¯£¬µ«ËæºóûÓÐARTµÄÇé¿öÏÂÔٴγöÏÖ²¡¶¾ÒÖÖÆ¡£

¡¡¡¡¡°HIV»áÒþ²ØÔÚijЩÃâÒßϸ°ûÖУ¬ÕâÖÖϸ°û±»³ÆÎªÇ±·ü²¡¶¾¿â£¬ËüÊÇÖÎÓúHIVµÄ¹Ø¼üÕϰ­¡£ÐÂÐÍHIVÖÎÁÆÖ¼ÔÚ»½ÐѲ¢°ÐÏòÕâЩ²¡¶¾¿â£¬ÓпÉÄÜÔÚûÓÐARTµÄ³¤ÆÚ²¡¶¾ÒÖÖÆÖз¢»ÓÖØÒª×÷Ó㬡±¹þ·ðҽѧԺ½ÌÊÚ¼æBeth Israel DeaconessҽѧÖÐÐIJ¡¶¾ºÍÒßÃçÑо¿ÖÐÐÄÖ÷ÈÎDan H. Barouch²©Ê¿Ëµ£¬¡°ÔÚÕâÏî¸ÅÄîÑéÖ¤µÄÁÙ´²Ç°Ñо¿ÖУ¬45%½ÓÊÜGS-9620ºÍPGT121µÄ¶¯ÎïÔÚÍ£Ö¹ARTºóûÓбíÏÖ³ö²¡¶¾·´µ¯£¬±íÃ÷ÕâÒ»×éºÏÖÎÁÆ¿ÉÄÜ»á°ÐÏò²¡¶¾±»ÒÖÖÆµÄºï×ÓÖеIJ¡¶¾¿â¡£¡±

¡¡¡¡¡°ÎÒÃÇÈÔÖÂÁ¦ÓÚÑо¿ºÍ¿ª·¢HIV¸ù³ý²ßÂÔ£¬ÕâЩÔÚCROI¹«²¼µÄÀ´×ÔHIV¸ÐȾµÄ¶¯ÎïÄ£ÐÍÁÙ´²Ç°Êý¾ÝÈÃÎÒÃDZ¶¸Ð¹ÄÎ裬ËüÃDZíÃ÷GS-9620ºÍPGT121×éºÏ¿ÉÄÜÔÚûÓÐARTµÄÇé¿öÏÂÓÕµ¼²¡¶¾»º½â£¬¡±GileadÑз¢²¿Ö´Ðи±×ܲüæÊ×ϯ¿ÆÑ§¹ÙNorbert W. Bishofberger²©Ê¿Ëµ£¬¡°GS-9620ĿǰÕýÔÚARTÒÖÖÆµÄHIV¸ÐȾÕßµÄ1bÆÚ¼ÁÁ¿µÝÔöÑо¿ÖнøÐÐÆÀ¹À£¬ÎÒÃÇÒѾ­½«PGT121ÑÜÉúÎïGS-9722ÍÆ½øµ½1ÆÚÊÔÑé½×¶Î¡£¡±

¡¡¡¡ÎÒÃÇ×£Ô¸ºóÐøµÄÁÙ´²ÊÔÑé½øÕ¹Ë³Àû£¬²¢ÆÚ´ýÔÚ²»¾ÃµÄ½«À´£¬ÈËÀàÖÕ½«Õ½Ê¤°¬×̲¡¡£

¡¡¡¡²Î¿¼×ÊÁÏ£º

¡¡¡¡¢Å Gilead's Preclinical Combo Trial Might Eradicate HIV

¡¡¡¡¢Æ Gilead Announces Data from New Preclinical Study Evaluating a Combination of an Investigational TLR7 Agonist and an Investigational HIV Envelope Targeting Antibody in SHIV-Infected, Virally Suppressed Monkeys

¡¡¡¡(À´Ô´£ºÒ©Ã÷¿µµÂ)


ÏÊ»¨

ÎÕÊÖ

À×ÈË

·¹ý

¼¦µ°

×îÐÂÆÀÂÛ

Archiver|ÊÖ»ú°æ|СºÚÎÝ|ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ  

GMT+8, 2023-1-27 06:21 , Processed in 0.077004 second(s), 19 queries .

Powered by ͬ־´óȫվ¶ÔÓÚÈκΰüº¬ÓÚ¡¢¾­ÓÉ¡¢Á´½Ó¡¢ÏÂÔØ»ò´ÓÈκÎÓë±¾ÍøÕ¾ÓйطþÎñ£¨ÒÔϼò³Æ[·þÎñ]£©Ëù»ñµÃ µÄÐÅÏ¢¡¢ÄÚÈÝ»ò¹ã¸æ£¨ÒÔϼò³Æ[×ÊÁÏ]£©£¬²»ÉùÃ÷»ò±£Ö¤ÆäÕýÈ·ÐÔ»ò¿É¿¿ÐÔ¡£ÄúÓڴ˽ÓÊܲ¢³ÐÈÏÐÅÀµÈκΠ[×ÊÁÏ]Ëù·¢ÉúµÄ·çÏÕ¶¼Ó¦×ÔÐге£¡£¶ÔÓÚÒò[·þÎñ]¡¢[×ÊÁÏ]ËùÉúµÄÈκÎÖ±½Ó¡¢¼ä½Ó¡¢¸½´øµÄ»òÒò´Ë¶øµ¼Ö µÄÑÜÉúÐÔËðʧ¸Å²»¸ºÔð¡£ °²»ÕÍ¬Ö¾ÍøÕ¾ÎªÃâ·ÑÍøÖ·Õ¾£¬ËùÓÐÁ¬½Ó¾ùÀ´×ÔÍøÉÏ£¬ÆäÏà¹ØÄÚÈÝÒ»¸ÅÓë±¾Õ¾Î޹أ¬±¾Õ¾²»¶ÔÏà¹ØÍøÕ¾ÄÚÈÝ ¸ºÔð£¡ÈçÄú·¢ÏÖ±¾Õ¾ÓÐÈκηǷ¨²»Á¼Á¬½Ó,ÇëÁ¢¼´¸æÖ®ÎÒÃÇ,ÎÒÃǽ«ÔÚµÚһʱ¼äÄÚɾ³ý.ÎÒÃǼá¾öÖ§³ÖºÍÅä ºÏרÏîÐж¯ X3.2

© 2001-2013 Comsenz Inc.

·µ»Ø¶¥²¿